Literature DB >> 31073973

De-escalation treatment of axilla in breast cancer.

G Corso1,2, V Galimberti3, P Veronesi3,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31073973     DOI： 10.1007/s12094-019-02129-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  5 in total

1.  Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

Authors:  Viviana Galimberti; Bernard F Cole; Giuseppe Viale; Paolo Veronesi; Elisa Vicini; Mattia Intra; Giovanni Mazzarol; Samuele Massarut; Janez Zgajnar; Mario Taffurelli; David Littlejohn; Michael Knauer; Carlo Tondini; Angelo Di Leo; Marco Colleoni; Meredith M Regan; Alan S Coates; Richard D Gelber; Aron Goldhirsch
Journal:  Lancet Oncol       Date:  2018-09-05       Impact factor: 41.316

2.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Authors:  Mila Donker; Geertjan van Tienhoven; Marieke E Straver; Philip Meijnen; Cornelis J H van de Velde; Robert E Mansel; Luigi Cataliotti; A Helen Westenberg; Jean H G Klinkenbijl; Lorenzo Orzalesi; Willem H Bouma; Huub C J van der Mijle; Grard A P Nieuwenhuijzen; Sanne C Veltkamp; Leen Slaets; Nicole J Duez; Peter W de Graaf; Thijs van Dalen; Andreas Marinelli; Herman Rijna; Marko Snoj; Nigel J Bundred; Jos W S Merkus; Yazid Belkacemi; Patrick Petignat; Dominic A X Schinagl; Corneel Coens; Carlo G M Messina; Jan Bogaerts; Emiel J T Rutgers
Journal:  Lancet Oncol       Date:  2014-10-15       Impact factor: 41.316

3.  Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial.

Authors:  O Gentilini; E Botteri; P Dadda; C Sangalli; C Boccardo; N Peradze; R Ghisini; V Galimberti; P Veronesi; A Luini; E Cassano; G Viale; U Veronesi
Journal:  Eur J Surg Oncol       Date:  2016-02-03       Impact factor: 4.424

4.  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Authors:  Armando E Giuliano; Karla V Ballman; Linda McCall; Peter D Beitsch; Meghan B Brennan; Pond R Kelemen; David W Ollila; Nora M Hansen; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow
Journal:  JAMA       Date:  2017-09-12       Impact factor: 56.272

5.  Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.

Authors:  Jana de Boniface; Jan Frisell; Yvette Andersson; Leif Bergkvist; Johan Ahlgren; Lisa Rydén; Roger Olofsson Bagge; Malin Sund; Hemming Johansson; Dan Lundstedt
Journal:  BMC Cancer       Date:  2017-05-26       Impact factor: 4.430
  5 in total
  1 in total

1.  Can axillary lymphadenectomy be avoided in breast cancer with positive sentinel lymph node biopsy? Predictors of non-sentinel lymph node metastasis.

Authors:  Sonia Martinez Alcaide; Carlos Alberto Fuster Diana; Julia Camps Herrero; Laia Bernet Vegue; Antonio Valdivia Perez; Eugenio Sahuquillo Arce; Juan Blas Ballester Sapiña; Pedro Juan Gonzalez Noguera; Jose Marcelo Galbis Caravajal
Journal:  Arch Gynecol Obstet       Date:  2022-05-03       Impact factor: 2.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.